COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Killed, 3 injured in Crash on Highway 79 Near Dugan Drive


2 Vehicles Collide in Fatal Aguanga Accident

Aguanga, CA (August 16, 2020) – One person was killed and three others were injured in a crash in Aguanga. The fatal accident occurred on the afternoon of August 16 on Highway 79.

A Subaru and a Dodge Challenger collided head-on on Highway 79, near Dugan Drive. One vehicle caught fire upon impact, while the other went off the road.

One person was killed in the crash. Three others suffered minor to major injuries. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Aguanga

#92536


May 18, 2020

Carl Nielsen Killed in Crash on Deep Creek Road

Dirt Bike Collides With Truck in Fatal Apple Valley Accident...


September 9, 2020

Cal/OSHA Fines 6 Employers

Bay Area Companies Failed to Protect Employees From Coronavirus...


September 4, 2020

1 Injured in Crash on East J Street

SUV Hits Bicyclist in Chula Vista Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.